MATRIX METALOPROTEINASE AS A POTENTIAL SALIVARY BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA

Astrid Widhowaty Santoso, Riani Setiadhi

Abstract


Introduction: Oral squamous cell carcinoma (OSCC) is the sixth most common cancer worldwide and the most prevalent form of oral cancer. The five-year survival rate for OSCC varies considerably depending on the stage of the disease, ranging from 40% to 60%. The majority of cases are diagnosed at an advanced stage, resulting in a significantly reduced life expectancy. Therefore, there is a clear need for effective strategies to detect cancer at an early stage. Aim: The objective of this article is to identify the potential of matrix metalloproteinase (MMP) as a salivary biomarker for the early detection of oral squamous cell carcinoma (OSCC). Review: Saliva is considered a potential source of biomarkers for oral cancer due to its continuous contact with cancerous lesions in the oral cavity and the various enzymes, hormones, antibodies, antimicrobial constituents, and cytokines it contains. MMP is an extracellular endopeptidase enzyme present in saliva and associated with the carcinogenesis process. It has been identified as a salivary biomarker for the early detection of OSCC. The levels of several MMP proteins in the saliva of OSCC patients have been found to be elevated, including MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-11, MMP-12, and MMP-13. Conclusion: The increased levels of salivary MMP, which were most specifically found in OSCC patients, included MMP-1, MMP-2, MMP-3, MMP-9, MMP-10, MMP-12, and MMP-13. This suggests that MMP may be a potential salivary biomarker for the early detection of OSCC

Keywords


Biomarker; Oral Cancer; OSCC; MMP; Saliva

Full Text:

PDF

References


Siddiqui IA. Oral Cancer Frequency at Different Sub Sites Presenting At a Tertiary Care Hospital in Karachi Pakistan. Global Journal of Otolaryngology. 2017;6(3):49–53.

Zaidi SJ, Riaz N, Iqbal A, Khan AA. Salivary Matrix Metalloproteinase (MMP)-1 as Non-Invasive Tool for The Diagnosis of Oral Squamous Cell Carcinoma (OSCC). Journal of the Pakistan Dental Association. 2021;30(1):18–23.

Kementerian Kesehatan RI. Pusat data dan informasi kesehatan: Stop kanker. Jakarta: Kementrian Kesehatan RI; 2018.

Ghanizada M, Jakobsen KK, Jensen JS, Wessel I, Filtenborg Tvedskov J, Grønhøj C, et al. The impact of comorbidities on survival in oral cancer patients: a population-based, case-control study. Acta Oncologica [Internet]. 2021;60(2):173–9. Available from: https://doi.org/10.1080/0284186X.2020.1836393

Hema Shree K, Ramani P, Sherlin H, Sukumaran G, Jeyaraj G, Don KR, et al. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma – a Systematic Review with Meta Analysis. Vol. 25, Pathology and Oncology Research. Pathology & Oncology Research; 2019. p. 447–53.

Assad DX, Mascarenhas ECP, de Lima CL, de Toledo IP, Chardin H, Combes A, et al. Salivary metabolites to detect patients with cancer: a systematic review [Internet]. Vol. 25, International Journal of Clinical Oncology. Springer Singapore; 2020. p. 1016–36. Available from: https://doi.org/10.1007/s10147-020-01660-7

Cristaldi M, Mauceri R, Di Fede O, Giuliana G, Campisi G, Panzarella V. Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: Current status and perspectives. Vol. 10, Frontiers in Psychology. 2019. p. 1–12.

Csosz É, Lábiscsák P, Kalló G, Márkus B, Emri M, Szabó A, et al. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers. PLoS ONE. 2017;12(5):1–21.

Chopra S, Bansal P, Bansal P. Biopsy of Oral Lesion -A Review Article. Journal of Advanced Medical and Dental Sciences Research (JAMDSR) [Internet]. 2020;8(1):184–6. Available from: www.jamdsr.com

Ghizoni JS, Nichele R, de Oliveira MT, Pamato S, Pereira JR. The utilization of saliva as an early diagnostic tool for oral cancer: microRNA as a biomarker [Internet]. Vol. 22, Clinical and Translational Oncology. Springer International Publishing; 2020. p. 804–12. Available from: https://doi.org/10.1007/s12094-019-02210-y

Kumar V, Abbas AK, Aster JC. Robbins & Cotran: Pathologic Basis of Disease. 10th ed. Turner JR, editor. Philadelpia: Elsevier; 2021.

Givony S. Oral squamous cell carcinoma (OSCC) an overview Medical Sciences Online issue Indexed in Index Copernicus. Journal of Medical Sciences [Internet]. 2020;8(13):67–74. Available from: www.medicsciences.com

Kumar SA, Indu S, Gautami D, VarRuchi S. Oral squamous cell carcinoma (oscc) in humans: Etiological factors, diagnostic and therapeutic relevance. Research Journal of Biotechnology. 2020;15(10):141–51.

Glick M, Greenberg MS, Lockhart PB, Challacombe SJ. Burket’s Oral Medicine. 13th ed. Philadelpia: Wiley Blackwell; 2021.

Choudhry N, Sarmad S, Waheed NA, Gondal AJ. Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma. Pakistan Journal of Medical Sciences. 2019;35(1):252–6.

Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, et al. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Frontiers in Oncology. 2019;9(December):1–21.

Shih LC, Li CH, Sun KT, Chen LY, Hsu CL, Hung YW, et al. Association of matrix metalloproteinase-7 genotypes to the risk of oral cancer in Taiwan. Anticancer Research. 2018;38(4):2087–92.

Münchow EA, Bottino MC. Recent Advances in Adhesive Bonding - The Role of Biomolecules, Nanocompounds, and Bonding Strategies in Enhancing Resin Bonding to Dental Substrates. Current oral health reports [Internet]. 2017/07/10. 2017 Sep;4(3):215–27. Available from: https://pubmed.ncbi.nlm.nih.gov/29177123

Rangasamy L, Di Geronimo B, Ortín I, Coderch C, Zapico JM, Ramos A, et al. Molecular imaging probes based on matrix metalloproteinase inhibitors (MMPIs). Vol. 24, Molecules. 2019.

Matrix H, Caldeira J, Laronha H. Structure and Function Function of of Human Matrix Metalloproteinase. Cell. 2020;1–18.

Cathcart J, Pulkoski-Gross A, Cao J. Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas. Genes and Diseases [Internet]. 2015;2(1):26–34. Available from: http://dx.doi.org/10.1016/j.gendis.2014.12.002

Hung YW, Tsai CW, Wu CN, Shih LC, Chen YY, Liu YF, et al. The contribution of matrix metalloproteinase-8 promoter polymorphism to oral cancer susceptibility. Vol. 31, In Vivo. 2017. p. 585–90.

Gkouveris I, Nikitakis N, Aseervatham J, Rao N, Ogbureke K. Matrix metalloproteinases in head and neck cancer: current perspectives. Metalloproteinases In Medicine. 2017;Volume 4:47–61.

van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutation research. 2011;728(1–2):23–34.

Kessenbrock K, Plaks V, Werb Z. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell. 2010;141(1):52–67.

Nguyen TTH, Sodnom-Ish B, Choi SW, Jung H Il, Cho J, Hwang I, et al. Salivary biomarkers in oral squamous cell carcinoma. Journal of the Korean Association of Oral and Maxillofacial Surgeons. 2020;46(5):301–12.

Anjum A, Hosein M. Diagnostic Importance of Saliva – An Overview. Journal of the Pakistan Dental Association. 2019;28(03):129–35.

Feng Y, Li Q, Chen J, Yi P, Xu X, Fan Y, et al. Salivary protease spectrum biomarkers of oral cancer. International Journal of Oral Science. 2019;11(1).

Lousada-Fernandez F, Rapado-Gonzalez O, Lopez-Cedrun JL, Lopez-Lopez R, Muinelo-Romay L, Suarez-Cunqueiro MM. Liquid biopsy in oral cancer. International Journal of Molecular Sciences. 2018;19(6):1–15.

Peng M, Chen C, Hulbert A, Brock M V., Yu F. Non-blood circulating tumor DNA detection in cancer. Vol. 8, Oncotarget. 2017. p. 69162–73.

Wang X, Kaczor-Urbanowicz KE, Wong DTW. Salivary Biomarkers in Cancer Detection. PMC. 2017;34(1):7.

Ishikawa S, Ishizawa K, Tanaka A, Kimura H, Kitabatake K, Sugano A, et al. Identification of salivary proteomic biomarkers for oral cancer screening. In Vivo. 2021;35(1):541–7.

Zhang CZ, Cheng XQ, Li JY, Zhang P, Yi P, Xu X, et al. Saliva in the diagnosis of diseases. International Journal of Oral Science. 2016;8(3):133–7.

Peisker A, Raschke GF, Fahmy MD, Guentsch A, Roshanghias K, Hennings J, et al. Salivary MMP-9 in the detection of oral squamous cell carcinoma. Medicina Oral, Patologia Oral y Cirugia Bucal. 2017;22(3):e270–5.

Chundru VNS, Nirmal RM, Srikanth B, Bojji M, Midhun N, Lakshmi BJ. Salivaomics for Oral Cancer Detection: An Insight. Journal of pharmacy & bioallied sciences [Internet]. 2021/06/05. 2021 Jun;13(Suppl 1):S52–6. Available from: https://pubmed.ncbi.nlm.nih.gov/34447042

Wong DTW. Salivaomics. Journal of the American Dental Association (1939). 2012 Oct;143(10 Suppl):19S-24S.

Kaur J, Srivastava R, Borse V. Biosensors and Bioelectronics Recent advances in point-of-care diagnostics for oral cancer. 2021;178(January).

Chu HW, Chang KP, Hsu CW, Chang IYF, Liu HP, Chen YT, et al. Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches. Molecular and Cellular Proteomics. 2019;18(9):1796–806.

Ghallab NA, Shaker OG. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clinical Oral Investigations. 2017;21(3):937–47.

Khan MSR, Siddika F, Xu S, Liu XL, Shuang M, Liang HF. Diagnosing oral squamous cell carcinoma using salivary biomarkers. Bangabandhu Sheikh Mujib Medical University Journal. 2018;11(1):1.

Kaur J, Jacobs R, Huang Y, Salvo N, Politis C. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clinical Oral Investigations. 2018;22(2):633–40.

Vyas T. Biopsy of Oral Lesion-A Review Article. Journal of Advanced Medical and Dental Sciences Research. 2018 Jan 1;6(1):27–35.

Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. Journal of oral biology and craniofacial research [Internet]. 2015/09/09. 2016;6(1):66–75. Available from: https://pubmed.ncbi.nlm.nih.gov/26937373

AlAli AM, Walsh T, Maranzano M. CYFRA 21-1 and MMP-9 as salivary biomarkers for the detection of oral squamous cell carcinoma: a systematic review of diagnostic test accuracy. International journal of oral and maxillofacial surgery. 2020 Aug;49(8):973–83.

Rodriguez-Archilla A, Carrion-Ruiz MB. Usefulness of salivary biomarkers in oral precancer and cancer. International Dental & Medical Journal of Advanced Research - VOLUME 2015. 2018;4(1):1–6.

Ghosh S, Singh P, Nambiar KS, Haragannavar VC, Augustine D, Sowmya S V., et al. Role of salivary biomarkers in the diagnosis of oral cancer: Mini review. Journal of Medicine, Radiology, Pathology and Surgery. 2018;5(3):7–10.

Tsai CW, Hsu HM, Wang YC, Chang WS, Shih LC, Sun KT, et al. Contribution of MMP2 promoter genotypes to oral cancer susceptibility, recurrence and metastasis in Taiwan. Anticancer Research. 2018;38(12):6821–6.

Ren ZH, Wu K, Yang R, Liu ZQ, Cao W. Differential expression of matrix metalloproteinases and miRNAs in the metastasis of oral squamous cell carcinoma. BMC Oral Health. 2020;20(1):1–13.

Fouad YA, Aanei C. Revisiting the hallmarks of cancer. American journal of cancer research [Internet]. 2017 May 1;7(5):1016–36. Available from: https://pubmed.ncbi.nlm.nih.gov/28560055

Shin YJ, Vu H, Lee JH, Kim HD. Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study. PLoS ONE [Internet]. 2021;16(3 March):1–15. Available from: http://dx.doi.org/10.1371/journal.pone.0248167

Chang YT, Chu LJ, Liu YC, Chen CJ, Wu SF, Chen CH, et al. Verification of saliva matrix metalloproteinase-1 as a strong diagnostic marker of oral cavity cancer. Cancers. 2020;12(8):1–18.

Smriti K, Ray M, Chatterjee T, Shenoy RP, Gadicherla S, Pentapati KC, et al. Salivary MMP-9 as a biomarker for the diagnosis of oral potentially malignant disorders and oral squamous cell carcinoma. Asian Pacific Journal of Cancer Prevention. 2020;21(1):233–8.

Dalirsani Z, Pakfetrat A, Delavarian Z, Hashemy SI, Mostaan LV, Abdollahnejad M, et al. Comparison of matrix metalloproteinases 2 and 9 levels in saliva and serum of patients with head and neck squamous cell carcinoma and healthy subjects. International Journal of Cancer Management. 2019;12(5):0–5.

Lai X, Li Q, Wu F, Lin J, Chen J, Zheng H, et al. Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming. Frontiers in Cell and Developmental Biology. 2020;8(August):1–13.

Vilen ST, Salo T, Sorsa T, Nyberg P. Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. The Scientific World Journal. 2013;2013.

Umashankar K, Jayaraj G, Sherlin HJ, Don K. Evaluation of matrix metalloproteinase 9 gene expression in oral squamous cell carcinoma and its clinicopathological correlation. National Journal of Maxillofacial Surgery. 2021;(12):339–43.

Deraz EM, Kudo Y, Yoshida M, Obayashi M, Tsunematsu T, Tani H, et al. MMP-10/stromelysin-2 promotes invasion of head and neck cancer. PLoS ONE. 2011;6(10).

Saleem Z, Shaikh AH, Zaman U, Ahmed S, Majeed MM, Kazmi A, et al. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma. BMC Oral Health [Internet]. 2021;21(1):1–8. Available from: https://doi.org/10.1186/s12903-021-01571-7

Holmström SB, Lira-Junior R, Zwicker S, Majster M, Gustafsson A, Åkerman S, et al. MMP-12 and S100s in saliva reflect different aspects of periodontal inflammation. Cytokine [Internet]. 2019;113:155–61. Available from: https://www.sciencedirect.com/science/article/pii/S1043466618302850




DOI: https://doi.org/10.33854/jbd.v11i1.1470

DOI (PDF): https://doi.org/10.33854/jbd.v11i1.1470.g544

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Astrid Widhowaty Santoso

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.